9887 — Nanjing Leads Biolabs Co Balance Sheet
0.000.00%
Last trade - 00:00- HK$17.57bn
- HK$16.13bn
- CNY177.26m
Annual balance sheet for Nanjing Leads Biolabs Co, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.
2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|
| Period Length: | — | — | — |
| Source: | PROSPECTUS | PROSPECTUS | PRESS |
| Standards: | IFRS | IFRS | — |
| Status: | Final | Final | Final |
| Cash | |||
| Cash and Equivalents | |||
| Short Term Investments | |||
| Cash and Short Term Investments | 348 | 539 | 1,548 |
| Total Inventory | |||
| Prepaid Expenses | |||
| Total Other Current Assets | |||
| Total Current Assets | 367 | 596 | 1,690 |
| Gross Property, Plant And Equipment | |||
| Accumulated Depreciation | |||
| Net Property, Plant And Equipment | 61.1 | 47.6 | 49 |
| Net Intangible Assets | |||
| Long Term Notes Receivable | |||
| Other Long Term Assets | |||
| Total Assets | 447 | 669 | 1,781 |
| Accounts Payable | |||
| Notes Payable / Short Term Debt | |||
| Current Portion of Long Term Debt / Capital Leases | |||
| Total Other Current Liabilities | |||
| Total Current Liabilities | 1,395 | 398 | 502 |
| Capital Lease Obligations | |||
| Total Long Term Debt | |||
| Total Debt | |||
| Total Other Liabilities | |||
| Total Liabilities | 1,396 | 404 | 516 |
| Common Stock | |||
| Retained Earnings (Accumulated Deficit) | |||
| Treasury Stock | |||
| Total Equity | -949 | 266 | 1,266 |
| Total Liabilities & Shareholders' Equity | 447 | 669 | 1,781 |
| Total Common Shares Outstanding |